Member Posts > Cardiol Therapeutics: Latest Press Releases and Advancements
Cardiol Therapeutics is making significant progress in cardiac care, with frequent updates demonstrating their ongoing commitment to developing treatments for heart diseases, especially pericarditis and myocarditis. In 2024, CardiolRx™ received widespread attention, particularly at the American Heart Association's Scientific Sessions, where its effectiveness in treating recurrent pericarditis was showcased.
Key Developments:
• MAvERIC-Pilot results presented at AHA 2024, highlighting CardiolRx™'s potential.
• Advancements in recurrent pericarditis trials, with plans for late-stage studies.
• Successful capital fundraising efforts to support continued research and innovation.
Cardiol remains focused on pioneering solutions for heart disease, addressing both its causes and symptoms. The press releases section on their website offers the latest updates on their progress and future milestones.

#CardiolTherapeutics #CardiolRx #HeartHealth #MedicalInnovation #Biotech #ClinicalTrials #Pericarditis #Myocarditis #HealthcareResearch

www.cardiolrx.com/investo...